skip to Main Content

COSTAction Meeting in Palermo!

Wrapping Up an inspiring COSTAction Meeting in Palermo!  

March 21st 2025 marked the fourth and final day of the COST Action CA20117 MyeInfoBank meeting, with working group session where brilliant minds came together to exchange ideas and spark scientific collaborations, focusing on “Converting molecular profiles of myeloid cells into biomarkers for inflammation and cancer“. 

Myeloid immune cells are important mediators in the pathology of many diseases, especially in diseases associated with chronic inflammation (DACI).  Recent advancements in molecular profiling technologies have led to the generation of large data sets, many of those not fully explored yet, but accessible to the entire scientific community via public data repositories. It is the aim of this COST Action to repurpose those data sets, retrieve and curate myeloid cell-specific information, and apply this information to develop novel biomarkers for DACI. To this end, Mye-InfoBank will utilise COST networking tools to enable the interaction of molecular biologists, bioinformaticians, immunobiologists, biobank coordinators and clinicians. The concerted activity of these experts on myeloid cell biology (either basic or clinical research) MYE, bioinformatics INFO, and bio-banking BANK, will transform complex molecular information into standardized and applicable biomarkers, which have the potential to improve clinical decision making in a number of socio-economically important diseases. 

This EU-funded initiative brings together researchers, bioinformaticians, and clinicians to identify novel markers of myeloid cells in DACI. With -omics technologies generating massive datasets—many still untapped—our goal is to curate, integrate, and reuse this wealth of information to uncover new biomarkers, ultimately validating them through access to bio-banks. 

 Exciting discussions, meaningful collaborations, and a shared vision for advancing research!  Thanks to Chiara Cipollina, Claudia Coronnello and Nicolina Sciaraffa (Ri.MED Foundation), Delia Cosgrove  (BIOME – at University of Duisburg-Essen) and to all the participants! 

Back To Top